Filing Details
- Accession Number:
- 0001209191-15-041014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 14:43:09
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 14:43:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1485003 | Eleven Biotherapeutics Inc. | EBIO | Pharmaceutical Preparations (2834) | 252025616 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Sq. West Tower 11F, 1-5-1 Otemachi Chiyoda-Ku Tokyo M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-05-08 | 33,400 | $13.23 | 1,923,226 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Weighted average from 239 transactions with prices ranging from $12.80 to $13.505. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.